Chronic Leukemia

Chronic Leukemia News

  • Mutations Tied to Ibrutinib Resistance in Leukemia In patients with chronic lymphocytic leukemia, mutations indicating acquired resistance to the Bruton tyrosine kinase (BTK) inhibitor ibrutinib may help guide therapy, researchers say.
  • Cellectis Gets U.S. Go-ahead to Test 'Off-the-Shelf' Cell Therapy Cellectis has won U.S. regulatory approval to run an early clinical trial using its gene edited cell therapy product UCART123 for blood cancers, boosting the French biotech firm's ambitions in the hot area of cancer research.

Chronic Leukemia Perspective